Literature DB >> 18279020

Effects of thyroid hormone analogs on lipid metabolism and thermogenesis.

Miriam O Ribeiro1.   

Abstract

Thyroid hormone affects in a myriad of biological processes such as development, growth, and metabolic control. Triiodothyronine (T3) is the biologically active form of thyroid hormone that acts through nuclear receptors, TRalpha and TRbeta, regulating gene expression. Given that the distribution of these receptors is heterogeneous amongst the different tissues, it is not surprising that some physiological effects of T3 are isoform specific. For example, while TRalpha is the dominant receptor in the brain and skeletal system and mediates most of the synergism between T3 and the sympathetic signaling pathway in the heart, TRbeta is abundant in liver and is probably the isoform that mediates most of the T3 effects on lipid metabolism. Thus, it makes sense to develop compounds that selectively act on either one of the TRs, allowing for the activation of specific T3-dependent pathways. This article reviews the recent progress made in this area, focusing on the physiological effects of compounds that lower serum cholesterol and decrease fat mass, as they spare skeletal muscle and bone masses, as well as the heart. The available studies indicate that achieving selective activation of different TR-mediated pathways is a promising strategy for treating lipid disorders and obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279020     DOI: 10.1089/thy.2007.0288

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  22 in total

Review 1.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

2.  Crossing the hurdles of thyroid hormone receptor-α activation.

Authors:  Miriam O Ribeiro; Antonio C Bianco
Journal:  Endocrinology       Date:  2011-03       Impact factor: 4.736

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  In vivo selective expression of thyroid hormone receptor α1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice.

Authors:  Jorge Suarez; Hong Wang; Brian T Scott; Haiyun Ling; Ayako Makino; Eric Swanson; Joan Heller Brown; Jorge A Suarez; Shera Feinstein; Julieta Diaz-Juarez; Wolfgang H Dillmann
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-05-21       Impact factor: 3.619

5.  In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.

Authors:  Carmen Grijota-Martínez; Eric Samarut; Thomas S Scanlan; Beatriz Morte; Juan Bernal
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

6.  Impaired metabolic effects of a thyroid hormone receptor beta-selective agonist in a mouse model of diet-induced obesity.

Authors:  Melany Castillo; Beatriz C G Freitas; Matthew L Rosene; Rafael A Drigo; Renata Grozovsky; Rui M B Maciel; Mary Elizabeth Patti; Miriam O Ribeiro; Antonio C Bianco
Journal:  Thyroid       Date:  2010-05       Impact factor: 6.568

7.  Novel cell-based assay for detection of thyroid receptor beta-interacting environmental contaminants.

Authors:  Diana A Stavreva; Lyuba Varticovski; Ludmila Levkova; Anuja A George; Luke Davis; Gianluca Pegoraro; Vicki Blazer; Luke Iwanowicz; Gordon L Hager
Journal:  Toxicology       Date:  2016-08-12       Impact factor: 4.221

8.  Single-nucleotide polymorphisms in chromosome 3p14.1- 3p14.2 are associated with susceptibility of type 2 diabetes with cataract.

Authors:  Hui-Ju Lin; Yu-Chuen Huang; Jane-Ming Lin; Jer-Yuarn Wu; Liuh-An Chen; Chao-Jen Lin; Yung-Ping Tsui; Chih-Ping Chen; Fuu-Jen Tsai
Journal:  Mol Vis       Date:  2010-07-01       Impact factor: 2.367

9.  Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1.

Authors:  Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-07-23

10.  Altered regulation of energy homeostasis in older rats in response to thyroid hormone administration.

Authors:  Stephane Walrand; Kevin R Short; Lydia A Heemstra; Colleen M Novak; James A Levine; Jill M Coenen-Schimke; K Sreekumaran Nair
Journal:  FASEB J       Date:  2013-12-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.